Should we focus on novel risk markers and screening tests to better predict and prevent cardiovascular disease?

Jonathan R. Enriquez, James A de Lemos

Research output: Contribution to journalArticle

6 Scopus citations

Abstract

Editor's Note: The following Point/Counterpoint articles were derived from a debate presentation sponsored by the American Society for Preventive Cardiology at the March 2010 meeting of the American Heart Association Council on Epidemiology and Prevention, titled " Should We Focus on Novel Risk Marker and Screening Tests to Better Predict and Prevent Cardiovascular Disease?" Dr. James de Lemos presented the pro side, titled " Novel Risk Markers and Screening Tests Will Improve the Prediction and Prevention of Cardiovascular Disease," and Dr. Donald Lloyd-Jones advocated the con side, titled " Better Implementation of Existing Knowledge Will Save More Lives Than All of the Novel Biomarkers in the World." The following articles include points from the debate, rebuttal, and questions raised by the audience. We thank all authors for sharing this debate with the readership.

Original languageEnglish (US)
Pages (from-to)152-159
Number of pages8
JournalPreventive Cardiology
Volume13
Issue number4
DOIs
Publication statusPublished - Sep 2010

    Fingerprint

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Public Health, Environmental and Occupational Health

Cite this